Despite the limitation of these retrospective studies, the evidence from the clinic indicates that CIC-rearranged sarcoma represents a novel and discrete tumor entity, which displays a decreased histological response to standard chemotherapy compared to EWS. The gene discussed is EWSR1; the disease is neoplasm.